4.4 mmol/L is optimal fasting glucose cutoff for GDM screening

4.4 mmol/L is optimal fasting glucose cutoff for GDM screening
A fasting plasma glucose value of 4.4 mmol/L is the optimal cut point for determining which pregnant Chinese women need a 75-g 2-h oral glucose tolerance test offered at 24 to 28 weeks' gestation, according to a study published online March 27 in Diabetes Care.

(HealthDay)—A fasting plasma glucose value of 4.4 mmol/L is the optimal cut point for determining which pregnant Chinese women need a 75-g 2-h oral glucose tolerance test offered at 24 to 28 weeks' gestation, according to a study published online March 27 in Diabetes Care.

Wei-Wei Zhu, M.D., from Peking University First Hospital in China, and colleagues analyzed the medical records and results of a 75-g 2-h (OGTT) from 24,854 pregnant women without known pre-gestational diabetes mellitus (pre-GDM).

The researchers found that a fasting plasma glucose cutoff value of 5.1 mmol/L identified 3,149 pregnant women (12.1 percent) with GDM. A fasting plasma glucose cutoff value of 4.4 mmol/L ruled out GDM in 15,369 women (38.2 percent) women, which would miss 12.2 percent of patients with mild GDM. The is 0.322, and the negative predictive value is 0.928.

"Fasting at 24 to 28 weeks' gestation could be used as a screening test to identify GDM patients in low-resource regions," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Journal information: Diabetes Care

Health News Copyright © 2013 HealthDay. All rights reserved.

Citation: 4.4 mmol/L is optimal fasting glucose cutoff for GDM screening (2013, April 16) retrieved 10 May 2024 from https://medicalxpress.com/news/2013-04-mmoll-optimal-fasting-glucose-cutoff.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Hemoglobin A1C inadequate for postpartum diabetes screening

 shares

Feedback to editors